Фоклерос

Фоклерос (erlotinib) is an oral medication used in cancer therapy. This EGFR inhibitor targets specific proteins to slow tumor growth. Suitable for patients under medical supervision. Always follow healthcare provider guidance.

Erlotinib is primarily used to treat certain types of non-small cell lung cancer and pancreatic cancer. It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking signals that promote cancer cell growth. Patients prescribed erlotinib often have specific genetic markers that make this treatment effective. It is not a first-line option for all cancer types.

Erlotinib is taken as a tablet and may cause mild to moderate side effects such as nausea, rash, or diarrhea. Some users report fatigue or loss of appetite. These effects vary by individual and are typically managed under medical supervision. Regular monitoring helps ensure the medication is well-tolerated.

Store erlotinib at room temperature away from moisture and heat. Keep the medication in its original packaging until ready to use. Avoid crushing or splitting tablets unless advised by a healthcare professional. Inform your doctor about all current medications and health conditions before starting treatment.

Erlotinib may interact with certain medications, including strong CYP3A4 inhibitors or inducers, which can affect its effectiveness. Grapefruit and grapefruit juice may also interact with erlotinib. Alcohol use should be discussed with a healthcare provider. Always review your full medication list with your doctor.